Brief: Societal Cdmo Enters Agreement With Atossa Therapeutics To Provide Clinical Trial Services (CTS)
23/05/2023 12:35
May 23 (Reuters) - Atossa Therapeutics Inc ATOS.O :
* SOCIETAL CDMO ENTERS AGREEMENT WITH ATOSSA THERAPEUTICS TO
PROVIDE CLINICAL TRIAL SERVICES (CTS) FOR INNOVATIVE SELECTIVE
ESTROGEN RECEPTOR MODULATOR
Source text for Eikon: ID:nGNX2jHfzm
Further company coverage: ATOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atossa Therapeutics
See all newsAtossa Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Atossa Therapeutics Q3 net loss narrows as clinical trial expenses decline
Brief: Atossa Therapeutics Executes Contingent Value Rights Agreement Providing Shareholders Participation In Potential Priority Review Voucher Value
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
Atossa Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary